WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced Deborah Covington, Dr.P.H., global head of observational studies and pregnancy registries, will join a panel of experts at the Late Phase Drug Development World Americas conference in Princeton, N.J., to discuss the methodologies for monitoring fetal outcomes associated with drug exposure in pregnancy.
